<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00123422</url>
  </required_header>
  <id_info>
    <org_study_id>F3845-R</org_study_id>
    <nct_id>NCT00123422</nct_id>
  </id_info>
  <brief_title>Innovation in Pulmonary Rehabilitation</brief_title>
  <official_title>Innovation Methods to Augment Pulmonary Rehabilitation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>VA Office of Research and Development</agency>
      <agency_class>U.S. Fed</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>VA Office of Research and Development</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study was to compare the effect of exercise treatment combined with
      breathing retraining (a computerized feedback program), with exercise treatment combined with
      heliox (a helium and oxygen combination), with exercise only in patients with moderate to
      severe chronic obstructive pulmonary disease. This was an 8-week intervention study.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Dynamic hyperinflation limits exercise tolerance in patients with chronic obstructive
      pulmonary disease (COPD). Recently, several innovative approaches have been developed to
      reduce the burden of dynamic hyperinflation. Two such innovations, ventilation-feedback
      training and Heliox supplementation during exercise show great promise and posit a reduction
      in dynamic hyperinflation as a key to their effectiveness. In our recently completed trial,
      when age, FEV1 and RV/TLC were controlled, exercise plus VF (E+VF) was superior to E training
      alone (E only) or VF training alone in improving exercise tolerance. The mechanism
      responsible for this difference was, in part, a reduction in exercise-induced dynamic
      hyperinflation secondary to a change in breathing pattern. In additional preliminary studies,
      we determined that exercise tolerance can be increased when patients exercise while inhaling
      Heliox. Similar to VF, the mechanism for exercise improvement with Heliox was a reduction in
      exercise-induced dynamic hyperinflation. Although both interventions are promising, there are
      no definitive data to support use of either intervention as a standard of care for pulmonary
      rehabilitation.

      Hypothesis/Research Questions Overview: The two primary hypotheses are that patients with
      moderate-severe COPD who successfully complete eight weeks of (a) E+VF training will achieve
      longer exercise duration than patients randomly assigned to E only and (b) E+heliox training
      will achieve longer exercise duration than patients randomly assigned to E only.

      Methods: This study was a randomized controlled clinical trial. After baseline testing is
      completed, 103 subjects with moderate-severe COPD were randomized into one of three groups:
      E+VF, E+Heliox and E training only. Follow-up testing was completed at 8 weeks. testing,
      activity monitoring, and dyspnea measurements. After baseline testing was completed,
      randomized subjects trained in the Physical Performance Laboratory three times weekly.
      Exercise prescriptions were standardized and based on data from the exercise stress test.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>October 2005</start_date>
  <completion_date type="Actual">September 2009</completion_date>
  <primary_completion_date type="Actual">August 2009</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Exercise Endurance</measure>
    <time_frame>14 weeks</time_frame>
    <description>Exercise endurance on a constant workrate treadmill test was measured at 14 weeks. The workload on the constant workrate treadmill test corresponded to the grade and speed that the participate had reached on a symptom-limited treadmill test when they reached 85% of their peak oxygen uptake value.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Inspiratory Capacity</measure>
    <time_frame>14 weeks</time_frame>
    <description>Inspiratory capacity measured during exercise is a measure of air-trapping (dynamic hyperinflation). Inspiratory capacity was measured at an isotime (same time) during the constant workrate treadmill test at baseline and 14 weeks.</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">103</enrollment>
  <condition>Pulmonary Disease</condition>
  <condition>Pulmonary Emphysema</condition>
  <arm_group>
    <arm_group_label>Breathing retraining</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Exercise training with computerized training program</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Heliox</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Exercise training with helium oxygen combination</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Exercise</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Exercise training</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Breathing retraining</intervention_name>
    <description>exercise training with computerized training program</description>
    <arm_group_label>Breathing retraining</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Heliox</intervention_name>
    <description>exercise training with a helium oxygen combination</description>
    <arm_group_label>Heliox</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Exercise</intervention_name>
    <description>exercise training</description>
    <arm_group_label>Exercise</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  40 years of age

          -  FEV1 70%

          -  FEV1/FVC &lt;70%

          -  RV/TLC &gt; 120%

        Exclusion Criteria:

          -  Respiratory infection/exacerbation within last 4 weeks

          -  Exercise limiting heart disease

          -  Primary asthma

          -  Congestive heart failure New York Heart Association (NYHA) Class III-IV

          -  Exercise limiting peripheral arterial disease or arthritis

          -  Inability to walk on a treadmill
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Eileen G. Collins, PhD RN</last_name>
    <role>Principal Investigator</role>
    <affiliation>Edward Hines Jr. VA Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Edward Hines, Jr. VA Hospital</name>
      <address>
        <city>Hines</city>
        <state>Illinois</state>
        <zip>60141-5000</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <results_reference>
    <citation>Collins EG, Jelinek C, O'Connell S, Butler J, McBurney C, Gozali C, Reda D, Laghi F. Contrasting breathing retraining and helium-oxygen during pulmonary rehabilitation in COPD: a randomized clinical trial. Respir Med. 2014 Feb;108(2):297-306. doi: 10.1016/j.rmed.2013.10.023. Epub 2013 Nov 5.</citation>
    <PMID>24238770</PMID>
  </results_reference>
  <verification_date>October 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 20, 2005</study_first_submitted>
  <study_first_submitted_qc>July 20, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 22, 2005</study_first_posted>
  <results_first_submitted>October 2, 2014</results_first_submitted>
  <results_first_submitted_qc>October 2, 2014</results_first_submitted_qc>
  <results_first_posted type="Estimate">October 7, 2014</results_first_posted>
  <last_update_submitted>October 6, 2014</last_update_submitted>
  <last_update_submitted_qc>October 6, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 16, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Breathing exercise</keyword>
  <keyword>Exercise Therapy</keyword>
  <keyword>Helium</keyword>
  <keyword>Oxygen inhalation therapy</keyword>
  <keyword>Pulmonary emphysema</keyword>
  <keyword>Pulmonary ventilation</keyword>
  <keyword>Rehabilitation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lung Diseases</mesh_term>
    <mesh_term>Emphysema</mesh_term>
    <mesh_term>Pulmonary Emphysema</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>192 patients were screened for eligibility in the study. 103 patients were randomly assigned to the one of the 3 groups. Patients were not randomized for the following reasons: PFT did not qualify (n=47), cardiac problems (n=13), changed mind (n=9), non-compliant (n=6), time constraints (n=5), too debilitated (n=3), other (n=6).</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>Breathing Retraining</title>
          <description>Exercise training with computerized training program
Breathing retraining: exercise training with computerized training program</description>
        </group>
        <group group_id="P2">
          <title>Heliox</title>
          <description>Exercise training with helium oxygen combination
Heliox: exercise training with a helium oxygen combination</description>
        </group>
        <group group_id="P3">
          <title>Exercise</title>
          <description>Exercise training
Exercise: exercise training</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="35"/>
                <participants group_id="P2" count="33"/>
                <participants group_id="P3" count="35"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>8-week Testing</title>
              <participants_list>
                <participants group_id="P1" count="32"/>
                <participants group_id="P2" count="30"/>
                <participants group_id="P3" count="27"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="31"/>
                <participants group_id="P2" count="27"/>
                <participants group_id="P3" count="25"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="4"/>
                <participants group_id="P2" count="6"/>
                <participants group_id="P3" count="10"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Physician Decision</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="2"/>
                <participants group_id="P3" count="6"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="2"/>
                <participants group_id="P3" count="2"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="2"/>
                <participants group_id="P3" count="2"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Breathing Retraining</title>
          <description>Exercise training with computerized training program
Breathing retraining: exercise training with computerized training program</description>
        </group>
        <group group_id="B2">
          <title>Heliox</title>
          <description>Exercise training with helium oxygen combination
Heliox: exercise training with a helium oxygen combination</description>
        </group>
        <group group_id="B3">
          <title>Exercise</title>
          <description>Exercise training
Exercise: exercise training</description>
        </group>
        <group group_id="B4">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="35"/>
            <count group_id="B2" value="33"/>
            <count group_id="B3" value="35"/>
            <count group_id="B4" value="103"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="68" spread="10"/>
                    <measurement group_id="B2" value="70" spread="9"/>
                    <measurement group_id="B3" value="69" spread="7"/>
                    <measurement group_id="B4" value="69" spread="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="1"/>
                    <measurement group_id="B4" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="33"/>
                    <measurement group_id="B2" value="31"/>
                    <measurement group_id="B3" value="34"/>
                    <measurement group_id="B4" value="98"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="35"/>
                    <measurement group_id="B2" value="33"/>
                    <measurement group_id="B3" value="35"/>
                    <measurement group_id="B4" value="103"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Smoking history</title>
          <description>Smoking history was measured in pack/years. This is the number of packs of cigarettes smoked per day multiplied by the number of years of smoking.</description>
          <units>pack/years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="62" spread="37"/>
                    <measurement group_id="B2" value="67" spread="40"/>
                    <measurement group_id="B3" value="68" spread="48"/>
                    <measurement group_id="B4" value="64" spread="42"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>FEV1 percent predicted</title>
          <description>The FEV1 (forced expiratory volume in 1 second) is a measure of pulmonary function. It is the amount of air that a person can blow out in one second. This value is reported as the percentage of predicted normal.</description>
          <units>percent</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="45" spread="14"/>
                    <measurement group_id="B2" value="46" spread="14"/>
                    <measurement group_id="B3" value="41" spread="13"/>
                    <measurement group_id="B4" value="44" spread="14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>RV/TLC percent predicted</title>
          <description>The RV/TLC (residual volume/total lung capacity) is a pulmonary function measure. It is an indication of air-trapping in the lungs. In general, a value over 120 percent predicted indicates that there is significant air-trapping.</description>
          <units>percent</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="165" spread="27"/>
                    <measurement group_id="B2" value="158" spread="24"/>
                    <measurement group_id="B3" value="161" spread="24"/>
                    <measurement group_id="B4" value="161" spread="25"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Exercise Endurance</title>
        <description>Exercise endurance on a constant workrate treadmill test was measured at 14 weeks. The workload on the constant workrate treadmill test corresponded to the grade and speed that the participate had reached on a symptom-limited treadmill test when they reached 85% of their peak oxygen uptake value.</description>
        <time_frame>14 weeks</time_frame>
        <population>We used an intent-to treat analysis using the last value carried forward. All participants were included in the final analysis.</population>
        <group_list>
          <group group_id="O1">
            <title>Breathing Retraining</title>
            <description>Exercise training with computerized training program
Breathing retraining: exercise training with computerized training program</description>
          </group>
          <group group_id="O2">
            <title>Heliox</title>
            <description>Exercise training with helium oxygen combination
Heliox: exercise training with a helium oxygen combination</description>
          </group>
          <group group_id="O3">
            <title>Exercise</title>
            <description>Exercise training
Exercise: exercise training</description>
          </group>
        </group_list>
        <measure>
          <title>Exercise Endurance</title>
          <description>Exercise endurance on a constant workrate treadmill test was measured at 14 weeks. The workload on the constant workrate treadmill test corresponded to the grade and speed that the participate had reached on a symptom-limited treadmill test when they reached 85% of their peak oxygen uptake value.</description>
          <population>We used an intent-to treat analysis using the last value carried forward. All participants were included in the final analysis.</population>
          <units>minutes</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="35"/>
                <count group_id="O2" value="33"/>
                <count group_id="O3" value="35"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="18.1" spread="13.4"/>
                    <measurement group_id="O2" value="14.5" spread="10.7"/>
                    <measurement group_id="O3" value="11.5" spread="7.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.015</p_value>
            <p_value_desc>Statistical tests were 2-sided and a p value of &lt; 0.05 was the criterion for statistical significance.</p_value_desc>
            <method>ANCOVA</method>
            <method_desc>The baseline value was the co-variate in this analysis.</method_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Inspiratory Capacity</title>
        <description>Inspiratory capacity measured during exercise is a measure of air-trapping (dynamic hyperinflation). Inspiratory capacity was measured at an isotime (same time) during the constant workrate treadmill test at baseline and 14 weeks.</description>
        <time_frame>14 weeks</time_frame>
        <population>Intent-to-treat analysis was used so data on all randomized patients were analyzed.</population>
        <group_list>
          <group group_id="O1">
            <title>Breathing Retraining</title>
            <description>Exercise training with computerized training program
Breathing retraining: exercise training with computerized training program</description>
          </group>
          <group group_id="O2">
            <title>Heliox</title>
            <description>Exercise training with helium oxygen combination
Heliox: exercise training with a helium oxygen combination</description>
          </group>
          <group group_id="O3">
            <title>Exercise</title>
            <description>Exercise training
Exercise: exercise training</description>
          </group>
        </group_list>
        <measure>
          <title>Inspiratory Capacity</title>
          <description>Inspiratory capacity measured during exercise is a measure of air-trapping (dynamic hyperinflation). Inspiratory capacity was measured at an isotime (same time) during the constant workrate treadmill test at baseline and 14 weeks.</description>
          <population>Intent-to-treat analysis was used so data on all randomized patients were analyzed.</population>
          <units>Liters</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="35"/>
                <count group_id="O2" value="33"/>
                <count group_id="O3" value="35"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.4" spread="0.7"/>
                    <measurement group_id="O2" value="2.0" spread="0.6"/>
                    <measurement group_id="O3" value="2.1" spread="0.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.05</p_value>
            <method>ANCOVA</method>
            <method_desc>The baseline value was the co-variate in this analysis.</method_desc>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Adverse events were collected during the time period that the patient was enrolled in the study. When the patient completed the study (after 14 week testing was completed), we stopped collecting adverse event information.</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Breathing Retraining</title>
          <description>Exercise training with computerized training program
Breathing retraining: exercise training with computerized training program</description>
        </group>
        <group group_id="E2">
          <title>Heliox</title>
          <description>Exercise training with helium oxygen combination
Heliox: exercise training with a helium oxygen combination</description>
        </group>
        <group group_id="E3">
          <title>Exercise</title>
          <description>Exercise training
Exercise: exercise training</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="35"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="35"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Blood and lymphatic system disorders</title>
            <event_list>
              <event>
                <sub_title>intracerebral bleed</sub_title>
                <description>Patient had a intercerebral bleed during the course of the study.</description>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="35"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="35"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Cardiac Event</sub_title>
                <description>Patients had chest pain or needed an intervention such as angioplasty.</description>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="35"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="35"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Neoplasms benign, malignant and unspecified (incl cysts and polyps)</title>
            <event_list>
              <event>
                <sub_title>lung cancer</sub_title>
                <description>A patient developed lung cancer during the study.</description>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="35"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="35"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="35"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="33"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="35"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Blood and lymphatic system disorders</title>
            <event_list>
              <event>
                <sub_title>cellulitis</sub_title>
                <description>Patient developed a cellulitis in his legs</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="35"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="35"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>COPD exacerbation</sub_title>
                <description>Exacerbation of COPD that lasted over 2 weeks and caused the patient to be withdrawn from the study.</description>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="35"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="33"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="35"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Eileen Collins</name_or_title>
      <organization>Edward Hines Jr. ,VA Hospital</organization>
      <phone>708-202-3525</phone>
      <email>eileen.collins@va.gov</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

